CA 125 Tumor Marker (Serum)
This test measures the level of CA 125, a protein often produced by certain types of ovarian cancer and sometimes by other cancers or conditions affecting the female reproductive system.
["CA 125 helps monitor cancer progression or treatment response in some cases."]
Key facts at a glance
- LOINC
- 2006-5
- Short code
- CA125
- Synonyms
- Cancer Ag125 SerPl Ql
- Category
- chemistry
- Sample
- serum
- Container
- Serum separator tube (SST) or red-top tube; plasma acceptable in lithium heparin or EDTA tube
- Units
- N/A
- Ref low
- 0
- Ref high
- 35
- Critical range
- 0.5 N/A – —
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- Immunoassay (Chemiluminescent or Electrochemiluminescent)
- CPT
- 86304
- SNOMED
- 104935009
- Specimen volume
- 1 mL serum or plasma (minimum 0.5 mL)
- Stability
- Room temperature: 8 hours; Refrigerated (2-8°C): 7 days; Frozen (-20°C or below): 3 months. Avoid repeated freeze-thaw cycles.
- Hemolysis max
- 100
- Lipemia max
- 1000
- Icterus max
- 40
- TAT
- 4–24 hours
- Order
- routine
What Is CA 125 Used For?
CA 125 is primarily used as a screening or monitoring tool for ovarian cancer, though it is not a definitive diagnostic test on its own. It may also be checked in patients with symptoms suggestive of ovarian or other gynecologic cancers, or in those undergoing treatment for these conditions. Levels can sometimes rise with other conditions, such as endometriosis or benign ovarian cysts, so results should be interpreted by your healthcare provider in the context of your overall health and medical history.
How Is the Test Collected?
A blood sample is drawn from a vein, usually in your arm, by a healthcare professional. You may feel a small pinch when the needle is inserted, but the procedure is quick and typically not painful afterward.
When Might You Need This Test?
Your doctor may recommend a CA 125 test if you have symptoms like persistent abdominal pain, bloating, or unexplained weight loss. It may also be part of routine monitoring for ovarian cancer patients or those with a family history of the disease. Always discuss test results with your healthcare provider to understand their relevance to your situation.
What Are Common Results?
Results are reported in international units per milliliter (IU/mL). Higher than normal levels may indicate ovarian cancer or other conditions, but they can also be elevated in non-cancerous situations. Your doctor will review your results with you and may recommend additional testing if needed.
Reference range
Normal: < 35 U/mL. Values above 35 U/mL may indicate malignancy or other conditions; clinical correlation required.N/A
No fasting required. Specimen collection may be performed at any time of day. Inform clinician of any recent pelvic examination, menstruation, or pregnancy as these may affect results.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
◆Associated findings1
Short name
CA 125
Frequently asked questions
Why might my CA 125 test be ordered if I don’t have symptoms of cancer?
Can CA 125 levels be affected by other medications or health conditions?
Is a CA 125 test always accurate, even if it’s positive?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 17, 2026. · Read our editorial policy